Grade 3 Hepatotoxicity following Fulvestrant, Palbociclib, and Erdafitinib Therapy in a Patient with ER-Positive/PR-Negative/HER2-Negative Metastatic Breast Cancer: A Case Report

Abstract Una donna di 49 anni con cancro al seno metastatico ER-positivo/PR-negativo/HER2-negativo ha sperimentato epatotossicità di grado 3 dopo l’inizio

Continue readingGrade 3 Hepatotoxicity following Fulvestrant, Palbociclib, and Erdafitinib Therapy in a Patient with ER-Positive/PR-Negative/HER2-Negative Metastatic Breast Cancer: A Case Report